Photodynamic therapy for facial dermatosis papulosa nigra: Efficacy and safety in a preliminary study
Dermatosis papulosa nigra (DPN) is a benign epidermal hyperplasia that affects patients’ appearance and threatens their physical and mental health. Photodynamic therapy (PDT) offers a non-invasive, effective treatment with low recurrence for skin disorders; however, its application for DPN has not been reported. Here, we treated 45 DPN patients at Changzhou First People’s Hospital with 10% 5-aminolevulinic acid (ALA) PDT once a week for four weeks, with a 3‑month follow-up. Post-treatment, the cure rate reached 71.1% and overall efficacy was 93.3%, with mild erythema, edema, and temporary pigmentation as the most common adverse effects. These results suggest that PDT is a promising and safe alternative for DPN treatment.
Authors
- Danmin Liu (ORCID: https://orcid.org/0000-0002-4031-1351)
- Ruzhi Zhang (ORCID: https://orcid.org/0000-0001-8292-0270)
- Fang Wang (ORCID: https://orcid.org/0000-0001-5608-6649)
- Zeyu Huang (ORCID: https://orcid.org/0009-0006-2898-8278)
Institutions
- Wannan Medical College (CN)
- Soochow University (TW)
Publication Details
- Journal
- Photodiagnosis and Photodynamic Therapy
- Published
- 2025-11-01
- DOI
- https://doi.org/10.1016/j.pdpdt.2025.105090
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00